References
Müller E.E, Camanni F, Genazzani A.R. Nomifensine in hyperprolactinemia states. J. Endocrinol. Invest. 7: 42, 1984.
Müller E.E., Genazzani A.R., Murru S. Nomifensine: diagnostic test in hyperprolactinemic states. J. Clin. Endocrinol. Metab. 47: 1352, 1977.
lannotta F, Fachinetti P., Fachinetti A., Pinotti G., Usellini L Nomifensine, TRH, and insulin-induced hypoglycemia test in the diagnosis of prolactinomas. J. Endocrinol. Invest. 6: 353, 1983.
Bansal S., Lee LA, Woolf P.D. Abnormal prolactin responsivity to dopaminergic suppression in hyperpolactinemic patients. Am. J. Med. 71: 961, 1981.
Serri O., Kuchel O., Bun N.T., Somma M. Differential effect of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects. J. Clin. Endocrinol. Metab. 56: 256, 1983.
Webb M.B., Thominet J.L, Baroswky H., Berelowitz M., Frohman L.A. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia. J. Clin. Endocrinol. Metab. 56: 1089, 1983.
Martin M.C., Weiner R.I., Monroe E.S., Roberts J.M., Licko V., Jaffe R.B. Prolactin secretion adenomas in women VII. Dopamine regulation of Prolactin secretion. J. Clin. Endocrinol. Metab. 59: 485, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liuzzi, A., Chiodini, P.G. More on nomifensine. J Endocrinol Invest 8, 183 (1985). https://doi.org/10.1007/BF03350679
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350679